Rekah Pharmaceutical Industry Ltd (REKA) — Financial Flexibility Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of ILA7.37 Million (operating CF ILA5.27 Million minus capex ILA2.10 Million) represents 0% of total liabilities (ILA279.47 Million). Check strategic asset allocation of Rekah Pharmaceutical Industry Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Rekah Pharmaceutical Industry Ltd across 20 annual periods. See REKA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rekah Pharmaceutical Industry Ltd (2004–2025)
Year-by-year free cash flow to debt coverage for Rekah Pharmaceutical Industry Ltd. For the full company profile including market capitalisation, see Rekah Pharmaceutical Industry Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | ILA19.98 Million | ILA12.95 Million | ILA279.47 Million | ▼ -42.1% |
| 2024 | 0.12x | ILA35.24 Million | ILA26.54 Million | ILA285.24 Million | ▲ +2.1% |
| 2023 | 0.12x | ILA39.84 Million | ILA28.35 Million | ILA329.14 Million | ▼ -25.4% |
| 2022 | 0.16x | ILA46.48 Million | ILA39.00 Million | ILA286.34 Million | ▲ +21.9% |
| 2021 | 0.13x | ILA35.16 Million | ILA21.17 Million | ILA264.02 Million | ▲ +12.4% |
| 2020 | 0.12x | ILA30.12 Million | ILA11.28 Million | ILA254.10 Million | ▼ -68.3% |
| 2019 | 0.37x | ILA79.31 Million | ILA33.91 Million | ILA211.89 Million | ▲ +72.5% |
| 2018 | 0.22x | ILA32.46 Million | ILA17.28 Million | ILA149.62 Million | ▼ -19.0% |
| 2017 | 0.27x | ILA40.27 Million | ILA23.80 Million | ILA150.33 Million | ▲ +60.2% |
| 2016 | 0.17x | ILA36.27 Million | ILA22.82 Million | ILA216.86 Million | ▲ +76.6% |
| 2015 | 0.09x | ILA18.95 Million | ILA5.81 Million | ILA200.17 Million | ▲ +7.1% |
| 2014 | 0.09x | ILA20.60 Million | ILA1.33 Million | ILA233.05 Million | ▲ +22.9% |
| 2013 | 0.07x | ILA16.09 Million | ILA11.71 Million | ILA223.65 Million | ▼ -32.0% |
| 2012 | 0.11x | ILA24.00 Million | ILA14.18 Million | ILA226.90 Million | ▲ +62.4% |
| 2010 | 0.07x | ILA14.61 Million | ILA6.73 Million | ILA224.18 Million | ▼ -60.5% |
| 2009 | 0.17x | ILA35.36 Million | ILA26.03 Million | ILA214.25 Million | ▲ +121.2% |
| 2008 | 0.07x | ILA17.30 Million | ILA6.57 Million | ILA231.87 Million | ▼ -1.6% |
| 2007 | 0.08x | ILA17.73 Million | ILA12.45 Million | ILA233.86 Million | ▲ +38.9% |
| 2005 | 0.05x | ILA11.36 Million | ILA4.27 Million | ILA208.15 Million | ▼ -63.0% |
| 2004 | 0.15x | ILA22.57 Million | ILA17.87 Million | ILA153.18 Million | — |